Berylliosis

disorder

SNOMED 8247009CUI C0005138

Overview

Berylliosis is a disorder.

Auto-generated from clinical reference data. Not a substitute for medical advice.

Treatments & Interventions

Cortisone

substance

Methylprednisolone acetate

substance

Prednisolone acetate

substance

Prednisolone sodium phosphate

substance

Prednisolone tertiary butylacetate

substance

Methylprednisolone

substance

Triamcinolone

substance

Triamcinolone diacetate

substance

Prednisolone

substance

Prednisone

substance

Cortisone acetate

substance

Triamcinolone acetonide

substance

Methylprednisolone sodium succinate

substance

Triamcinolone hexacetonide

substance

Methylprednisolone aceponate

substance

Prednisolone sodium metazoate

substance

Research Evidence

Peer-reviewed studies linked via MeSH term "Beryllioses" from the MEDLINE/PubMed database.

Sort:

Occupational exposure to beryllium and cancer risk: a review of the epidemiologic evidence.

[object Object], [object Object], [object Object] · Crit Rev Toxicol · 2012

PMID: 22276590Meta-Analysis

Systematic review: Progression of beryllium sensitization to chronic beryllium disease.

[object Object], [object Object], [object Object] et al. · Occup Med (Lond) · 2012

PMID: 22705916Meta-Analysis

5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.

[object Object], [object Object], [object Object] et al. · Lung · 2018

PMID: 29080069RCT

Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease.

[object Object], [object Object], [object Object] et al. · Respir Med · 2012

PMID: 22974830RCTFull text (PMC)

Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69.

[object Object], [object Object], [object Object] et al. · Respir Res · 2005

PMID: 16098233RCTFull text (PMC)

Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.

[object Object], [object Object], [object Object] et al. · J Immunol · 2022

PMID: 35418504ReviewFull text (PMC)

[Sarcoidosis and berylliosis].

[object Object], [object Object], [object Object] et al. · Internist (Berl) · 2022

PMID: 35397695Review

The emerging role of inorganic elements as potential antigens in sarcoidosis.

[object Object], [object Object] · Curr Opin Pulm Med · 2021

PMID: 34175859Review

[Management of occupational health for adverse health effects of beryllium and its compounds in workplaces - Recent trends and issues in Japan].

[object Object], [object Object] · Sangyo Eiseigaku Zasshi · 2021

PMID: 32788509Review

Chronic Beryllium Disease: Update on a Moving Target.

[object Object], [object Object], [object Object] et al. · Chest · 2020

PMID: 32768458Review

Search all PubMed articles for Berylliosis

Research data from MEDLINE/PubMed

Related Conditions

Acute berylliosis(child)

Subacute berylliosis(child)

Chronic berylliosis(child)

Hepatic granulomas in berylliosis(child)

Poisoning by beryllium(parent)

Metallosis(parent)

Inflammatory disorder of lower respiratory tract(parent)

Lung disorder(parent)

Inflammation of specific body organs(parent)

Quick Facts

SNOMED CT: 8247009
UMLS CUI: C0005138
Fully Specified Name: Berylliosis (disorder)
Specialists: 0
Diagnostic Biomarkers: 0
Known Treatments: 16

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.